Abstract:Background: Mounting evidence, consistent with our previous study, showed that gamma-aminobutyric acid type A receptor (GABAAR) played an indispensable role in airway inflammation and mucus hypersecretion in asthma. Monocyte chemotactic protein-inducing protein 1 (MCPIP1) was a key negative regulator of inflammation. Recent studies showed that inflammation was largely suppressed by enhanced MCPIP1 expression in many inflammatory diseases. However, the role and potential mechanism of MCPIP1 in airway inflammation and mucus hypersecretion in asthma were still not well studied. This study was to explore the role of MCPIP1 in asthmatic airway inflammation and mucus hypersecretion in both mice and BEAS-2B cells, and its potential mechanism.Methods: In vivo, mice were sensitized and challenged by ovalbumin (OVA) to induce asthma. Airway inflammation and mucus secretion were analyzed. In vitro, BEAS-2B cells were chosen. Interleukin (IL)-13 was used to stimulate inflammation and mucus hypersecretion in cells. MCPIP1 Lentiviral vector (LA-MCPIP1) and plasmid-MCPIP1 were used to up-regulate MCPIP1 in lung and cells, respectively. MCP-1, thymic stromal lymphopoietin (TSLP), mucin 5AC (MUC5AC), MCPIP1, and GABAAR beta 2 expressions were measured in both lung and BEAS-2B cells. Immunofluorescence staining was performed to observe the expression of GABAAR beta 2 in cells.Results: MCPIP1 was up-regulated by LA-MCPIP1 (P < 0.001) and plasmid-MCPIP1 (P < 0.001) in lung and cells, respectively. OVA-induced airway inflammation and mucus hypersecretion, OVA-enhanced MCP-1, TSLP, MUC5AC, and GABAAR beta 2 expressions, and OVA-reduced MCPIP1 were significantly blunted by LA-MCPIP1 in mice (all P < 0.001). IL-13-enhanced MCP-1, TSLP, MUC5AC, and GABAAR beta 2 expressions, and IL-13-reduced MCPIP1 were markedly abrogated by plasmid-MCPIP1 in BEAS-2B cells (all P < 0.001).Conclusion: The results of this study suggested that OVA and IL-13-induced airway inflammation and mucus hypersecretion were negatively regulated by MCPIP1 in both lung and BEAS-2B cells, involving GABAAR signaling pathway.

Epithelial miR-141 regulates IL-13–induced airway mucus production

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma

Mir-143 Inhibits Interleukin-13-induced Inflammatory Cytokine and Mucus Production in Nasal Epithelial Cells from Allergic Rhinitis Patients by Targeting IL13Rα1

Mir-330 Regulates Interleukin-13-induced MUC5AC Secretion by Targeting Munc18b in Human Bronchial Epithelial Cells

miRNA-based identification of SEC14L3 deregulation in murine experimental asthma

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells

Epithelial Cell-Derived Micro RNA-146a Generates Interleukin-10-producing Monocytes to Inhibit Nasal Allergy.

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

The miR-9-5p/KLF5/IL-1β Axis Regulates Airway Smooth Muscle Cell Proliferation and Apoptosis to Aggravate Airway Remodeling and Inflammation in Asthma

Resistin-like Molecule-β (Relm-Β) Influences Airways Epithelial Remodelling by Inducing Mucin and Transforming Growth Factor-β2 Gene Expression

Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13-stimulated airway epithelial cells

Reduced miR-513a-5p expression in COPD may regulate airway mucous cell hyperplasia through TFR1-dependent signaling

Role of IL-13Ra2 in Modulating IL-13 Induced MUC5AC and Ciliary Changes in Healthy and CRSwNP Mucosa

MiR-143-3p Controls TGF-β1-induced Cell Proliferation and Extracellular Matrix Production in Airway Smooth Muscle Via Negative Regulation of the Nuclear Factor of Activated T Cells 1.

Lyn Kinase Represses Mucus Hypersecretion by Regulating IL-13-induced Endoplasmic Reticulum Stress in Asthma.

Monocyte Chemotactic Protein-Inducing Protein 1 Negatively Regulating Asthmatic Airway Inflammation And Mucus Hypersecretion Involving Gamma-Aminobutyric Acid Type A Receptor Signaling Pathway In Vivo And In Vitro

Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma

Mycoplasma Pneumoniae Modulates STAT3-STAT6/EGFR-FOXA2 Signaling to Induce Overexpression of Airway Mucins

Mir-511-3p Limits Allergic Inflammation Through M2 Macrophage Polarization And Modulating Ccl2 Expression